Products & ReviewLife Sciences

KRIBIOLISA™ Semaglutide ELISA

ELISA for the quantitative determination of Semaglutide in serum and plasma.

Request Pricing
KRISHGEN BioSystems

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

GLP-1 receptor agonist medicines, also called incretin mimetics, are a type of incretin-based medicine for type 2 diabetes that control pancreatic function. These medicines (Exenatide, Semaglutide, Lixisenatide, and Liraglutide) copy, or mimic, the action of GLP-1 made by your body.

Krishgen’s range of ELISA for GLP-1 agonists can be used for pharmacokinetic studies, including dosage regimen and therapy development.

About the Semaglutide assay:

  • Uses highly specific antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity
  • Recovery rates are 80 - 120%
  • Validated as per US FDA guidelines for Bioassays
  • Optimized for matrix effects to ensure higher sensitivity
  • Uses the innovator drug as calibrator, and is optimized for biosimilars studies
  • Calibrator Range: 0 ng/ml-3000 ng/ml
  • Sensitivity: 50 ng/ml
  • Sample Type: serum and plasma
  • Reactivity: Human
  • Shipping Condition: 2 - 8 Deg C
  • Detection Method: Colorimetric
  • Usage: For Research Use Only
  • Research Area: Diabetes

Product Overview

Links